secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amphastar Pharmaceuticals, Inc. (AMPH)
CIK:        0001297184
Form:       8-K
Filed at:   2026-07-13T10:01:01+00:00
Accession:  0001104659-26-082772
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Amphastar appoints Anthony Pierce to board, expands to 11 directors
-------------------------------------------------------------------

- Board increased from 10 to 11 directors; Anthony Pierce appointed as Class III director effective July 9, 2026.
- Pierce is independent under Nasdaq standards; no committee assignments at this time.
- Annual cash retainer of $55,000 (pro-rated); initial equity grant of $300,000 (50% RSUs, 50% options) vests on first anniversary.
- Standard indemnification agreement to be entered with Pierce; no reportable transactions under Item 404(a).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1297184/000110465926082772/0001104659-26-082772-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1297184/000110465926082772/amph-20260709x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-082772

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer